(Q39849140)

15 September 2017

Antimicrobial activities of BMY-28142, cefbuperazone, and cefpiramide compared with those of other cephalosporins (English)

1 reference

15 September 2017

N J Khan

1

1 reference

15 September 2017

J A Bihl

2

1 reference

15 September 2017

R F Schell

3

1 reference

15 September 2017

J L LeFrock

4

1 reference

15 September 2017

S J Weber

5

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 October 1984

1 reference

Antimicrobial Agents and Chemotherapy

15 September 2017

1 reference

15 September 2017

26

1 reference

15 September 2017

4

1 reference

15 September 2017

585-590

1 reference

Comparative in vitro study in new cephalosporins

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179970

The new beta-lactamase-stable cephalosporins

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179970

Metabolic fate of [14C]SM-1652, a new antipseudomonal cephalosporin, after parenteral administration to rats

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179970

In vitro antibacterial activity of SM-1652, a new broad-spectrum cephalosporin with antipseudomonal activity

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179970

In vitro antibacterial activity of cefpiramide

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179970

Third-generation and investigational cephalosporins: I. Structure-activity relationships and pharmacokinetic review.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179970

Comparison of ceftriaxone and traditional therapy of bacterial meningitis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179970

Third-Generation and Investigational Cephalosporins: II. Microbiologic Review and Clinical Summaries

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179970

Cefmenoxime penetration into gallbladder bile and tissue

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179970

Mechanism of Action, Antimicrobial Activity, Pharmacology, Adverse Effects, and Clinical Efficacy of Cefotaxime

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179970

Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179970

Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179970

In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179970

Antibacterial activities of SM-1652 compared with those of other broad-spectrum cephalosporins

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179970

Antimicrobial Activity of Cefmenoxime Compared with Those of Other Cephalosporins

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179970

Comparative in vitro activities of cefpiramide and apalcillin against anaerobic bacteria

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179970

The antibacterial activity in vitro and β-lactamase stability of the new cephalosporin HR 810 in comparison with five other cephalosporins and two aminoglycosides

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6549120

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In vitro Antimicrobial Activity of Ceftizoxime

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6549120

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.26.4.585

1 reference

15 September 2017

1 reference

15 September 2017

1 reference